Mechanistically, SRGN can facilitate chemoresistance by cross-talking with the transcriptional coactivator YAP to maintain the stemness of breast cancer cells in vivo and in vitro (Zhang Z. et al., 2020). This evidence concerns the gene SRGN and breast carcinoma.